Pharmaceutical Product Information
Roaccutane® (isotretinoin)
Notice of Divestment: Roaccutane® (Isotretinoin) 10 mg and 20 mg Capsules
Roche has completed the global divestment of Roaccutane® to CHEPLAPHARM Schweiz GmbH. The Package Insert (PI) below reflects the last Roche-owned version approved by Health Sciences Authority (HSA), prior to the transfer of ownership. To access the latest PI, please contact CHEPLAPHARM’s appointed local product registrant and distributor in Singapore, Zuellig Pharma Pte Ltd.
Healthcare Professionals
Should you face issues with accessing the product information, please contact us via tel: +65-6735 0550 or click here